tiprankstipranks
Advertisement
Advertisement
Xbrane Biopharma to Re-submit Ranibizumab Biosimilar Application to FDA
PremiumCompany AnnouncementsXbrane Biopharma to Re-submit Ranibizumab Biosimilar Application to FDA
5M ago
Xbrane Biopharma Advances Xdivane Clinical Trial with First Patient Inclusion
Premium
Company Announcements
Xbrane Biopharma Advances Xdivane Clinical Trial with First Patient Inclusion
5M ago
Xbrane Biopharma Completes Reverse Stock Split
Premium
Company Announcements
Xbrane Biopharma Completes Reverse Stock Split
5M ago
Xbrane Biopharma to Present Interim Report for January-September 2025
PremiumCompany AnnouncementsXbrane Biopharma to Present Interim Report for January-September 2025
6M ago
Xbrane Biopharma Announces 2026 AGM Nomination Committee
Premium
Company Announcements
Xbrane Biopharma Announces 2026 AGM Nomination Committee
6M ago
Xbrane Biopharma Faces FDA Setback on Ranibizumab Biosimilar
Premium
Company Announcements
Xbrane Biopharma Faces FDA Setback on Ranibizumab Biosimilar
6M ago
Xbrane Biopharma Strengthens Financial Position and Advances Biosimilar Portfolio
PremiumCompany AnnouncementsXbrane Biopharma Strengthens Financial Position and Advances Biosimilar Portfolio
8M ago
7XB Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
7XB Earnings this Week: How Will it Perform?
8M ago
Xbrane Biopharma Announces Interim Report Presentation for H1 2025
Premium
Company Announcements
Xbrane Biopharma Announces Interim Report Presentation for H1 2025
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100